Evidence map›Paper›PMID 32420336›Full record

ReviewBioMed research international2020

Research Progress on Chemical Constituents and Anticancer Pharmacological Activities of

Yuwei Wang, Xiao Yu, Lingna Wang, Fang Zhang, Yongqing Zhang

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. New Phenylpropanoid fromCurrent pharmaceutical design · 2026
    Review
  3. Mitigation of Diabetes Mellitus UsingJournal of diabetes research · 2024
    Article
  4. Review
  5. Formulation, characteristics and anti-bacterial effects ofJournal of Taibah University Medical Sciences · 2022
    Article
  6. Article
  7. Flavonoids from the GenusPharmaceuticals (Basel, Switzerland) · 2021
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuwei WangCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID https://orcid.org/0000-0003-1477-0914
Xiao YuShandong Medicine Technician College, Tai'an 271016, China.
Lingna WangCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID https://orcid.org/0000-0003-1411-5012
Fang ZhangCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID https://orcid.org/0000-0002-1506-3384
Yongqing ZhangCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.ORCID https://orcid.org/0000-0002-2711-6770
Shandong University of Traditional Chinese Medicine · CNShandong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, PhytogenicAntioxidantsPlant ExtractsEuphorbiaHumansNeoplasmsAntineoplastic Agents, PhytogenicAntioxidantsPlant Extracts

Identifiers

PMID32420336
PMCPMC7201523
OpenAlexW2999990786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.